11:16 AM EST, 01/06/2025 (MT Newswires) -- European equities trading in the US as American depositary receipts were sharply higher late Monday morning, as the S&P Europe Select ADR Index rose 1.6% to 1,315.5.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and 3D printer company Materialise (MTLS), which climbed 20% and 6% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) and semiconductor company Sequans Communications ( SQNS ) that increased almost 5% and 3%, respectively.

The worst decliners in continental Europe were pharmaceutical company Novo Nordisk ( NVO ) and consumer goods giant Unilever ( UL ) losing roughly 2% each. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and Natuzzi (NTZ), which were down nearly 2% and 1%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ), (AKTX) and alcoholic beverage company Diageo ( DEO ) , gaining 6% and 3%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and insurance firm Prudential (PUK), which were up 2.6% and 2.9%, respectively.

The worst decliners in the UK and Ireland were biopharmaceutical company TC Biopharm ( TCBP ) and communications company WPP ( WPP ) , shedding 11% and 2% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) , which dropped 2.